Tag Archives | cancer vaccines immunotherapy

Rayno Life Science Stocks: YTD Review Part 1-FBT Up 49%

Part 1 Biopharmaceutical Stocks-New Highs Were Hit on December 10 Five Straight Years of Gains in Biotech-the IBB is up 292% since Dec 18, 2009 Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to invest in the biotech market is with […]

Continue Reading 0

Energy Weakness Rolls Over To Biotech Stocks Update-1… 12/12

Crude Trade Roils Markets-But Biotech Is Still A Safe Haven Second Worst Week of the Year-Late Day Trading Hit By Selling As the market becomes more volatile we should look at how the energy trade is affecting other asset classes. Certainly materials and industrials are being hit over the past month. With respect to healthcare […]

Continue Reading 0

Bio Investor Forum #2: T-Cell Therapies and Cancer Targets

Genetically Modified T-cells: Gene Therapy Is Back! Here are some quick notes and an overview of the companies at Bio: Immuno-Oncology  is one of the hottest new areas of biopharmaceutical development and on October 7  BIO presented a Therapeutic Session on “T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets”. […]

Continue Reading

ASCO Oncology Stocks: Recap and Scoreboard- AGIO, MDVN, SGEN Winners

High Profile Biotechnology Companies with ASCO Presence Investors and traders waited toward the end of the ASCO Annual Meeting week to buy their favorite stocks. The biotech sector overall was boosted after the close of the meeting after a brief sell-off on June 2 and 3. Most biopharmaceutical stocks peaked in late February so ASCO […]

Continue Reading

Rayno Life Science Portfolio: ILMN, PCYC, RGDX

Market Can’t Stay Down in Quiet Trading After a couple of lackluster trading days the market perked up as economic news continues positive with retail sales up for the  fourth consecutive month and many analysts believing Europe is coming out of recession. And the Icahn effect is back as Carl Icahn reveals his Apple (AAPL) […]

Continue Reading